A major UK Biobank study shows that inconsistent sleep timing, not just sleep duration, is associated with increased risk for 172 diseases, including liver cirrhosis and cardiovascular conditions.
New research shows that exposure to PFAS chemicals may increase the risk of type 2 diabetes by disrupting metabolism and affecting blood sugar regulation.
A University of Bristol study finds trained detection dogs can identify Parkinson's disease with up to 98% accuracy by smelling skin swabs, offering promise for early, non-invasive diagnosis.
A new global study reveals that people diagnosed with dementia are living longer than before, thanks to earlier diagnosis and advancements in care that reduce the risk of death post-diagnosis.
A WHO report reveals that social connection improves health and lowers the risk of early death, with one in six people experiencing loneliness globally.
Cardiff University spin-out Draig Therapeutics has been awarded £107m ($140m) to advance the development of novel therapies for major neuropsychiatric disorders.
There is a beacon of hope for patients with a rare genetic disorder called Werner Syndrome as researchers unveil a groundbreaking discovery: Nicotinamide riboside, a vitamin B3 derivative, reverses premature ageing.
A groundbreaking study from the Paul Scherrer Institute (PSI) in collaboration with Inselspital–Bern University Hospital has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161.
